Economic impact assessment from the use of a mobile app for the self-management of heart diseases by patients with heart failure in a Spanish region

Journal of Medical Systems

Volumn 38, Issue 9, 2014, Pages

  Cano Martín, José Antonio ^a   Martínez Pérez, Borja ^a   De La Torre Diéz, Isabel ^a   López Coronado, Miguel ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

App; Cost effectiveness; Economic assessment; Heart failure; Mobile health (mHealth)

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEART DISEASE; HEART FAILURE; HIDDEN MARKOV MODEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILE APPLICATION; SELF CARE; SPAIN; COST BENEFIT ANALYSIS; ECONOMICS;

COST-BENEFIT ANALYSIS; FEMALE; HEART FAILURE; HUMANS; MALE; MOBILE APPLICATIONS; SELF CARE; SPAIN;

EID: 84905560304     PISSN: 01485598     EISSN: 1573689X     Source Type: Journal    
DOI: 10.1007/s10916-014-0096-z     Document Type: Article

References (49)

1. World Health Organization (2013) A Global Brief on Hypertension, Silent Killer, global Public Health Crisis. http://apps.who.int/iris/bitstream/10665/ 79059/1/WHO-DCO-WHD-2013.2-eng.pdf?ua=1. Accessed 26 March 2014.
2. World Health Organization, Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Organization, World Health, 2009.
3. Martínez-Pérez, B., de la Torre-Díez, I., and López-Coronado, M., Sainz-De-Abajo B (2014) Comparison of Mobile Apps for the Leading Causes of Death Among Different Income Zones: A Review on Literature and Apps Stores. JMIR Mhealth Uhealth 2 (1):e1, 2014.
4. Forouzanfar MH, Moran AE, Flaxman AD, Roth G, Mensah GA, Ezzati M, et al. (2012) Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010. Glob Heart 2012;7 (4):331-342.
5. Casper, M., Nwaise, I., Croft, J. B., Hong, Y., and Fang, J., Greer S (2010) Geographic disparities in heart failure hospitalization rates among Medicare beneficiaries. J Am Coll Cardiol 55(4):294-299, 2010.
6. World Health Organization (2013) Cardiovascular diseases (CVDs) Fact sheet No 317. http://www.who.int/mediacentre/factsheets/fs317/en/index.html. Accessed 26 March 2014.
7. Martínez-Pérez, B., de la Torre-Díez, I., and Candelas-Plasencia, S., López-Coronado M (2013) Development and evaluation of tools for measuring the Quality of Experience (QoE) in mHealth applications. J Med Syst 37(5):9976, 2013.
8. IDC (2013) Press Release: Strong Demand for Smartphones and Heated Vendor Competition Characterize the Worldwide Mobile Phone Market at the End of 2012. http://www.idc.com/getdoc.jsp? containerId=prUS23916413#.UVBKiRdhWCn. Accessed 26March 2013.
9. World Health Organization, mHealth: New horizons for health through mobile technologies: Based on the findings of the second global survey on eHealth (Global Observatory for eHealth Series, Volume 3). Organization, World Health, 2011.
10. Martínez-Pérez, B., de la Torre-Díez, I., López-Coronado, M., Sainz-de-Abajo, B., and Robles, M., García-Gómez JM (2014) Mobile clinical decision support systems and applications: a literature and commercial review. J Med Syst 38(1):4, 2014.
11. Koo, H. R., Lee, Y. J., Gi, S., Khang, S., Lee, J. H., Lee, J. H., Lim, M. G., and Park, H. J., Lee JW (2014) The effect of textile-based inductive coil sensor positions for heart rate monitoring. J Med Syst 38(2):2, 2014.
12. Baig, M. M., Gholamhosseini H (2013) Smart health monitoring systems: an overview of design and modeling. J Med Syst 37(2):9898, 2013.
13. Bert, F., Giacometti, M., and Gualano, M. R., Siliquini R (2013) Smartphones and health promotion: a review of the evidence. J Med Syst 38(1):9995, 2014.
14. Gagnon, M. P., Desmartis, M., Labrecque, M., Car, J., Pagliari, C., Pluye, P., Frémont, P., Gagnon, J., and Tremblay, N., Légaré F (2012) Systematic review of factors influencing the adoption of information and communication technologies by healthcare professionals. J Med Syst 36(1):241-277, 2012.
15. Wang, K., Yamauchi, K., Li, P., Kato, H., Kobayashi, M., and Kato, K., Shimizu Y (2008) Cost-effectiveness of implantable cardioverter-defibrillators in Brugada syndrome treatment. J Med Syst 32(1):51-57, 2008.
16. Logeswaran R (2009) Cost effective patient location monitoring system using webcams. J Med Syst 2009;33 (5):399-407.
17. Li, K., Naganawa, S., Wang, K., Li, P., Kato, K., Li, X., and Zhang, J., Yamauchi K (2012) Study of the cost-benefit analysis of electronic medical record systems in general hospital in China. J Med Syst 36 (5):3283-3291, 2012.
18. Ridderstolpe, L., Johansson, A., Skau, T., and Rutberg, H., Ahlfeldt H (2002) Clinical process analysis and activity-based costing at a heart center. J Med Syst 26(4):309-322, 2002. (Pubitemid 38438027)
19. Hsieh, N. C., Chang, C. Y., Lee, K. C., and Chen, J. C., Chan CH (2012) Technological innovations in the development of cardiovascular clinical information systems. J Med Syst 36(2):965-978, 2012.
20. Tseng, K. C., and Hsu, C. L., Chuang YH (2013) Designing an intelligent health monitoring system and exploring user acceptance for the elderly. J Med Syst 37(6):9967, 2013.
21. Pevnick, J. M., Claver, M., Dobalian, A., Asch, S. M., Stutman, H. R., and Tomines, A., Fu P Jr (2012) Provider stakeholders' perceived benefit from a nascent health information exchange: a qualitative analysis. J Med Syst 36(2):601-613, 2012.
22. BBVA Foundation (2014) The public health system in Spain and its autonomous communities: sustainability and reforms. http://www.scielosp.org/pdf/ csc/v16n6/16.pdf. Accessed 24 March 2014
23. Ministry of Health, Social Services and Equality (2014). https://www.msssi.gob.es/estadEstudios/estadisticas/sisInfSanSNS/finGastoSanit. htm. Accessed 24 March 2014
24. Ministry of Health, Social Services and Equality. Indicators and Statistics (2014). http://icmbd.es/indicadorAction.do?method=list. Accessed 25 March 2014
25. Naveiro-Rilo, M., Diez-Juárez, D., Flores-Zurutuza, L., Rodríguez-García, M., and Rebollo-Gutiérrez, A., Romero Blanco A (2012) Quality of life in patients with heart failure: view from primary health care. Gac Sanit 26(5):436-443, 2012.
26. Naimark, D., Krahn, M. D., Naglie, G., Redelmeier, D. A., and Detsky, A. S., (1997) Primer on medial decision analysis: part 5. Working with Markov processes. Med Decis Making 17:152-159, 1997. (Pubitemid 27157030)
27. Boden, M., and Stern, E., User Perspectives. RTD Evaluation Toolbox. Assessing the Socio-Economic Impact of RTD-Policies, Seville, European Commission-Joint Research Centre, IPTS, pp. 1-14, 2002.
28. Navarro H, King K, Ortegon E, Pacheco C (2006) Impact assessment methodology guideline ex-ante and ex-post of social programs in the fight against poverty. Methodological application. Latin American Institute and the Caribbean for economic and Social Planning (ILPES). Santiago de Chile.
29. Polt, W., and Red, J., Evaluation methodologies-Introduction. RTD Evaluation Toolbox. Assessing the Socio-Economic Impact of RTD-Policies, Seville, European Commission-Joint Research Centre, IPTS, pp. 65-70, 2002.
30. Eichler, H. G., Kong, S. X., Gerth, W. C., and Mavros, P., Jonsson B (2004) Use of cost-effectiveness analysis in health- care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7(5):518-528, 2004. (Pubitemid 39390832)
31. Weinstein, M. C., Decision rules for incremental cost-effectiveness analysis. In: Jones, A. M. (Ed.), The Elgar Companion to health economics. Edwar Elgar, Cheltenham, pp. 469-478, 1998.
32. Gafni, A., Birch S (1993) Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J 148:913-917, 1993. (Pubitemid 23125540)
33. López-Bastida, J., Oliva, J., Antoñanzas, F., García-Altés, A., Gisbert, R., Mar, J., and Puig-Junoy, J., Spanish recommendations on economic evaluation of health technologies). Informes de Evaluación de Tecnologías Sanitarias 2008, 2008.
34. Villar Álvarez F, Banegas Banegas JR (2003) Las enfermedades cardiovasculares y sus factores de riesgo en España: hechos y cifras. Informe SEA 2003. Madrid: Ergon
35. Baena, J. M., Del Val, J. L., Tomás, J., Martínez, J. L., Martín, R., González, I., et al., (2005) Epidemiología de las enfermedades cardiovasculares y factores de riesgo en atención primaria. Rev Esp Cardiol 58:367-73, 2005.
36. Anguita Sánchez M, Muñiz García J, Crespo Leiro MG, Jiménez Navarro M, De Teresa Galván E, Alonso-Pulpón L, et al. (2006) Prevalencia de la insuficiencia cardiaca en España: un estudio poblacional. Resultados del estudio de prevalencia en la insuficiencia cardiaca en España (PRICE). Rev Esp Cardiol 2006;59 (2):57.
37. Rubido, C., Introduction to the use of Markov models in pharmacoeconomic analysis. Farmacia Hospitalaria 2000:24(4), 2000.
38. Ministry of Health, Social Services and Equality (2014) Funding and health spending. https://www.msssi.gob.es/estadEstudios/estadisticas/ sisInfSanSNS/finGastoSanit.htm. Accessed 26 March 2014.
39. Ministry of Health, Social Services and Equality (2014) Health Statistics - Certificates of Discharge of the National Health System Register. http://www.msssi.gob.es/estadEstudios/estadisticas/cmbdhome.htm. Accessed 27 March 2014.
40. National Statistical Institute (2014) Deaths according to cause of death 2011.http://www.ine.es . Accessed 26 March 2014.
41. Villar, F., Banegas, J. R., and Rodríguez, F., Rey J (1998) Mortalidad cardiovascular en España y sus comunidades autónomas (1975-1992). Med Clin 110:321-327, 1998. (Pubitemid 128527980)
42. de Rivas, B., Permanyer-Miralda, G., Carlos Brotons, C., et al., (2008) Health-related quality of life in unselected outpatients with heart failure across Spain in two different health care levels. Magnitude and determinants of impairment: the INCA study. Qual Life Res 17:1229-1238, 2008.
43. Alla, F., Briançon, S., Guillemin, F., et al., EPICAL investigators (2002) Self-rating of quality of life provides additional prognostic information in heart failure: insights into the EPICAL study. Eur J Heart Fail 4:337-343, 2002. (Pubitemid 35190359)
44. Graf von der Schulenberg, J. M., The influence of economic evaluation studies on health care decision-making. Ios Press, Amsterdam, 2000.
45. Briggs, A., Sculpher M (1998) An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 13:397-409, 1998. (Pubitemid 28140699)
46. Daly, E., Roche, M., Barlow, D., et al., (1992) HRT: an analysis of benefit, risks and costs. Br Med Bull 48:368-400, 1992.
47. Ministry of Health, Social Services and Equality (2014) Analysis and development of GDR in the National Health System. http://www.msssi.gob.es/ estadEstudios/estadisticas/docs/analisis.pdf. Accessed 31 March 2014.
48. TicSalut (2010) Catalan Remote Management Evaluation Project. Evaluation of the effectiveness in Catalonia for the remote management of patients with heart failure (motive). http://www.ticsalut.cat/observatori/innova-tic-salut/13/ carme-catalan-remote-management-evaluation-motiva. Accessed 31 March 2014.
49. Castilla y León Regional Government (2014) Website of official statistics from Castile and Leon. http://www.jcyl.es. Accessed 31 March 2014.